drugset / Trial / NCT00002423
A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir
Treatment
Summary
This study will compare the safety and effectiveness of two anti-HIV drug combinations in fighting HIV infection in patients whose viral loads (levels of HIV in the blood) rose with other anti-HIV drug treatments.
Timeline
- Start
- 1999-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INDINAVIR ANHYDROUS | Other / unclassified | 800 mg | — |
| Subject | Nelfinavir | Other / unclassified | 1250 mg | — |
| Background | Abacavir | Other / unclassified | 300 mg | — |
| Background | Amprenavir | Other / unclassified | 1200 mg | — |
| Background | Lamivudine | Other / unclassified | 150 mg | — |